Intellia Therapeutics newest breakthrough signals a bright future for treating serious hereditary conditions, offering profound implications for millions of patients worldwide.

  Intellia Therapeutics is one of the leading companies at the forefront of developing in vivo (inside the body) CRISPR/Cas9 gene editing th...